CJC-1295 DAC 5mg
Quality & Assurance
• COA available on every batch
• Fast Australia-wide dispatch
• Secure encrypted checkout
• Discreet, carefully packaged delivery
CJC-1295 (With DAC) – 5 mg Research Peptide
NRG Peptide Kingdom | 99% Purity | Research Use Only
⸻
Product Overview
CJC-1295 (with Drug Affinity Complex, DAC) is a long-acting synthetic analogue of growth hormone–releasing hormone (GHRH). The DAC modification enables prolonged plasma stability and extended receptor interaction, making this peptide a valuable tool for studying sustained endocrine signaling dynamics in controlled laboratory environments.
In research settings, CJC-1295 (DAC) is utilized to investigate growth hormone secretion patterns, receptor desensitization kinetics, and downstream metabolic signaling over extended timeframes.
This compound is supplied strictly as a research chemical for laboratory and in-vitro scientific applications.
⚠️ Not for human or veterinary use.
⸻
Key Features
- 5 mg lyophilized peptide per vial
- ≥ 99% purity (HPLC verified)
- Long-acting DAC-modified formulation
- Research grade material
- Individually sealed sterile glass vial
- Batch-specific Certificate of Analysis (COA) included in product gallery
- Manufactured for advanced endocrine and receptor-signaling research applications
⸻
Intended Use
This product is supplied strictly for laboratory research use only (RUO).
It is intended for:
- Growth hormone–releasing hormone (GHRH) receptor studies
- Long-acting endocrine signaling and kinetics research
- Hormone pulsatility and secretion-pattern modeling
- Peptide–receptor interaction analysis
- In-vitro biochemical and molecular biology experiments
Not approved for therapeutic, diagnostic, or veterinary use.
⸻
Regulatory Notice
For laboratory research use only. Not for human or veterinary administration. Not approved by the TGA, FDA, EMA, or any regulatory authority for therapeutic or diagnostic use. The purchaser assumes all responsibility for lawful handling, storage, and use.